"Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis
about
Possible clinical outcome measures for clinical trials in patients with multiple sclerosisClinical measures of disease severity and outcome in psoriasis: a critical appraisal of their quality.Hematopoietic stem cell transplantation for multiple sclerosis: collaboration of the CIBMTR and EBMT to facilitate international clinical studies.Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial.Recombinant human interferon beta in relapsing-remitting multiple sclerosis: a review of the major clinical trials.Randomised, double blind, placebo controlled study of interferon beta-1a in relapsing-remitting multiple sclerosis analysed by area under disability/time curvesDisability outcome measures in therapeutic trials of relapsing-remitting multiple sclerosis: effects of heterogeneity of disease course in placebo cohorts.Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial.Defining secondary progressive multiple sclerosis.Anti-inflammatory disease-modifying treatment and short-term disability progression in SPMS.Induction of sTNF-R1 and sTNF-R2 by interferon beta-1b in correlation with clinical and MRI activity.Switch to natalizumab versus fingolimod in active relapsing-remitting multiple sclerosis.Assessment of different treatment failure criteria in a cohort of relapsing-remitting multiple sclerosis patients treated with interferon β: Implications for clinical trials
P2860
Q30433837-5FE12E5F-ED37-4652-B92F-B1FB375291B8Q33723592-068CC437-2EFF-4E8E-84A7-F66B2BF00250Q33965239-63A2E1F9-6219-40BF-9C1C-94EB4C478D7BQ34021279-44C64B14-64B4-4FFB-8501-8DD51972A3EAQ34022587-F0B51C5D-A8AF-4880-8537-EAF893819B4AQ35453326-B135FD2D-CFF0-4051-82C7-81179D25812AQ35456042-24D00425-3294-48F4-813B-2BFF53FE05A7Q35475689-BFBDBB93-1C1E-45FE-9156-C8DC6684543EQ38843046-91349B51-511B-490C-97D2-09A1D3804A2EQ48607199-023E1D71-9EE1-41FA-8F83-69183B35AE12Q48967125-3A4A64A6-12A2-423C-ABA4-9FD3BB078959Q53078951-475F9C41-4B87-46D1-937F-2B8DEF4B8282Q57602043-B093071B-718C-4F9C-8CA9-4E579A2B7937
P2860
"Summary measure" statistic for assessing the outcome of treatment trials in relapsing-remitting multiple sclerosis
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
"Summary measure" statistic fo ...... g-remitting multiple sclerosis
@ast
"Summary measure" statistic fo ...... g-remitting multiple sclerosis
@en
type
label
"Summary measure" statistic fo ...... g-remitting multiple sclerosis
@ast
"Summary measure" statistic fo ...... g-remitting multiple sclerosis
@en
prefLabel
"Summary measure" statistic fo ...... g-remitting multiple sclerosis
@ast
"Summary measure" statistic fo ...... g-remitting multiple sclerosis
@en
P2093
P2860
P921
P356
P1476
"Summary measure" statistic fo ...... g-remitting multiple sclerosis
@en
P2093
P2860
P304
P356
10.1136/JNNP.64.6.726
P407
P577
1998-06-01T00:00:00Z